| Product Name | MF | CAS | Details |
|---|
| Menin-MLL inhibitor 26 | C27H29F3N6O3S | 2440018-29-9 | Details |
| BRM/BRG1 ATP Inhibitor-4 | C25H32N6O3S | 2422030-94-0 | Details |
| SARS-CoV-2 3CLpro-IN-7 | C24H17ClN2O6 | 1164478-67-4 | Details |
| Loxoprofenol-SRS tromethamine | C19H31NO6 | 2582872-01-1 | Details |
| BRM/BRG1 ATP Inhibitor-3 | C26H25N5O2S2 | 2368901-31-7 | Details |
| Topoisomerase II inhibitor 7 | C32H28BrN5O5S | 2697171-03-0 | Details |
| Eleven-Nineteen-Leukemia Protein IN-2 | C22H23N5O2 | 2894121-78-7 | Details |
| Metallo-β-lactamase-IN-9 | C13H12N6O3S | 1802363-75-2 | Details |
| (-)-15-Deoxyspergualin | 89149-10-0 | Details |
| (R,R)-Reboxetine mesylate | C20H27NO6S | 105017-39-8 | Details |
| ML-077 | C17H16N4OS2 | 1135304-61-8 | Details |
| CB-892 | C15H14N2O4 | 1032336-22-3 | Details |
| Velagliflozin proline hydrate | C28H34N2O7 | 1661838-94-3 | Details |
| Cyclic-di-GMP diammonium | C20H27N11O14P2 | 609343-82-0 | Details |
| PF-06815345 hydrochloride | C27H30Cl2FN9O4 | 2334434-49-8 | Details |
| 6-trans-12-epi-Leukotriene B4 | C20H32O4 | 71548-19-1 | Details |
| KRAS G12C inhibitor 37 | C35H39F3N8O2 | 2241720-04-5 | Details |
| KRAS G12C inhibitor 40 | C34H36ClFN10O2 | 2660014-14-0 | Details |
| Antiarrhythmic agent-1 | C25H27N3O4S | 136081-07-7 | Details |
| Antibacterial agent 64 | C29H20ClN3O6S2 | 618865-52-4 | Details |
| MAO-B ligand-1 | C19H19N5O4S | 1010879-39-6 | Details |
| Asterriquinol D dimethyl ether | C26H24N2O4 | 287117-66-2 | Details |
| VU0621623 | C20H21F2N5O3S | 1115899-15-4 | Details |
| N 0840 | C11H15N5 | 109292-91-3 | Details |
| P-CAB agent 2 hydrochloride | C22H26ClFN2O4S | 2209911-80-6 | Details |
| KYN-101 | C22H19FN6 | 2247950-73-6 | Details |
| KRAS G12C inhibitor 41 | C36H37ClFN9O2 | 2660014-65-1 | Details |
| Topoisomerase IV inhibitor 2 | C33H30FN7O6S | 2883403-36-7 | Details |
| R995045 | C16H15N4O3S | 1285536-79-9 | Details |
| 3-Chlorogentisyl alcohol | C7H7ClO3 | 32744-80-2 | Details |
| Ladostigil hydrochloride | C16H21ClN2O2 | 209394-18-3 | Details |
| Cathepsin K inhibitor 3 | C30H31FN4O4S | 1694638-70-4 | Details |
| Antileishmanial agent-13 | C17H10BrClN4O | 853725-86-7 | Details |
| Antituberculosis agent-6 | C27H20F2N2O3 | 2874263-72-4 | Details |
| KRAS G12D inhibitor 10 | C33H41ClN8O2 | 2648551-54-4 | Details |
| Antibacterial agent 124 | C16H17ClFN3O2 | 2304448-00-6 | Details |
| Hsp90-IN-17 hydrochloride | C21H21ClN4O7 | 1253584-63-2 | Details |
| Phosphoglycolohydroxamic acid | C2H6NO6P | 51528-59-7 | Details |
| Carbonic anhydrase inhibitor 12 | C27H22BrN5O5S2 | 2883451-38-3 | Details |
| Eleven-Nineteen-Leukemia Protein IN-3 | C28H27N5O2 | 2894121-83-4 | Details |
| Tubulin polymerization-IN-40 | C24H22FNO5 | 2921670-94-0 | Details |
| S1P5 receptor agonist-1 | C20H24F3NO3 | 2373330-78-8 | Details |
| Sodium ((2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9(6H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl diphosphate | C10H16N5NaO11P2 | 9652-27-6 | Details |
| Neuroinflammatory-IN-3 | C19H19ClO3 | 1202404-23-6 | Details |
| Anti-inflammatory agent 33 | C22H15N3O5S | 2816993-09-4 | Details |
| D,L-erythro-PDMP hydrochloride | C23H39ClN2O3 | 80943-40-4 | Details |
| P2X7 receptor antagonist-3 | C17H12ClF3N6O | 1627900-92-8 | Details |
| 5-Iminodaunorubicin hydrochloride | C27H31ClN2O9 | 67324-99-6 | Details |
| ST101036 | C18H21F3N4 | 1018143-39-9 | Details |
| KRAS G12C inhibitor 39 | C37H43N9O2 | 2326522-16-9 | Details |
| KRAS G12C inhibitor 35 | C31H27ClF2N6O3 | 2650550-87-9 | Details |
| ADRA1D receptor antagonist 1 free base | C15H13ClN4O | 1191908-24-3 | Details |
| PI3K/mTOR Inhibitor-12 | C27H27F2N9O4S | 2891692-83-2 | Details |
| α-Synuclein inhibitor 8 | C24H20N2O6 | 2883627-64-1 | Details |
| 3β-Hydroxy-hop-22(29)-ene | C30H50O | 58801-23-3 | Details |
| PUN-96956 | C21H33ClN2 | 1144496-95-6 | Details |
| Larotinib mesylate hydrate | C25H30ClFN4O7S | 2097129-93-4 | Details |
| DYRKs-IN-1 hydrochloride | C30H31Cl2N7O4 | 1386980-55-7 | Details |
| Mitochondria degrader-1 | C33H49ClFN7O8S | 2241669-05-4 | Details |
| Teslexivir hydrochloride | C35H37BrClN3O4 | 1075281-70-7 | Details |
| KRAS G12C inhibitor 45 | C32H33F2N5O5S | 2670380-74-0 | Details |
| Antiproliferative agent-17 | C26H28N2OS | 2882206-08-6 | Details |
| CypD-IN-29 | C26H20FN5O2S | 1115335-95-9 | Details |
| KRAS G12C inhibitor 20 | C33H37ClFN7O3 | 2640858-10-0 | Details |
| Antituberculosis agent-8 | C25H19F3N2O3 | 2874263-74-6 | Details |
| ATM-3507 trihydrochloride | C37H47ClFN5O2 | 2438679-30-0 | Details |
| Enpp/Carbonic?anhydrase-IN-2 | C23H24FNO4S | 2883495-39-2 | Details |
| Topoisomerase IV inhibitor 1 | C34H32FN7O6S | 2883403-42-5 | Details |
| Eleven-Nineteen-Leukemia Protein IN-1 | C27H33N7O2 | 2894121-68-5 | Details |
| MRS2768 tetrasodium salt | 2567869-47-8 | Details |
| Mtb-cyt-bd oxidase-IN-6 | C20H27NO | 1246461-10-8 | Details |
| SARS-CoV-2 3CLpro-IN-5 | C22H26ClF2N5O4 | 2913186-57-7 | Details |
| ZINC09410451 | C24H27ClN4O3 | 1093065-66-7 | Details |
| ZINC32540717 | C23H26N4O3 | 1010869-76-7 | Details |
| CPD7 HCl | C20H20ClNO3 | 1158740-21-6 | Details |
| Difluorocyclooctyne-CH2-COOH | C10H12F2O2 | 1047997-31-8 | Details |
| E09241 | C11H9ClN2O2 | 1043110-13-9 | Details |
| Antibacterial agent 19 | C16H16F2N2O4 | 79660-59-6 | Details |
| Tilpisertib fosmecarbil | C35H36ClN8O7P | 2567459-64-5 | Details |
| Cap-dependent endonuclease-IN-7 | C36H28FN3O7S | 2485715-97-5 | Details |
| β2AR/M-receptor agonist-2 | C36H49ClN4O7S | 1017857-38-3 | Details |
| Glucocorticoid receptor modulator 1 | C24H23ClN2O4S | 2868357-11-1 | Details |
| KRAS G12C inhibitor 32 | C29H30Cl3FN6O3 | 2756739-00-9 | Details |
| COR167 | C28H38N2O2 | 1048038-90-9 | Details |
| 673-A | C15H13NO | 109437-62-9 | Details |
| Atorvastatin hemicalcium trihydrate | C33H39CaFN2O6 | 344920-08-7 | Details |
| DSP-1053 benzenesulfonate | C32H38BrNO7S | 1176326-78-5 | Details |
| (D-Met2,Pro5)-Enkephalinamide | C30H40N6O6S | 63307-63-1 | Details |
| (+)-Dihydrocalanolide A | C22H28O5 | 183904-53-2 | Details |
| LC kinetic stabilizer-1 | C27H31N5O3 | 2495750-19-9 | Details |
| Lagociclovir valactate | C18H25FN6O6 | 1001670-19-4 | Details |
| SRT 1720 dihydrochloride | C25H24ClN7OS | 2468639-77-0 | Details |
| SARS-CoV-2 3CLpro-IN-6 | C22H15NO7 | 302821-53-0 | Details |
| TP-S1-68 | C15H9ClN4S | 120187-04-4 | Details |
| LC kinetic stabilizer-2 | C28H31N3O3 | 2495750-20-2 | Details |
| NK1 receptor antagonist 2 | C31H35F7N4O2 | 579475-17-5 | Details |
| ID110460002 | C20H25FN4O | 1172882-21-1 | Details |
| RORγt inverse agonist 26 | C27H21F7N2O5S | 2738333-10-1 | Details |
| Antiproliferative agent-20 | C23H18N2O6 | 1344715-94-1 | Details |
| PI3K/Akt/CREB activator 1 | C19H15F4NO3 | 2708177-73-3 | Details |
| Product Total： Product Page： | ||||
| 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 | ||||